skip to content

Centre For Cancer Genetic Epidemiology

 
Read more at: Seminar : Innovative Epigenetic Approaches for Primary and Secondary Prevention of Women’s Cancers

Seminar : Innovative Epigenetic Approaches for Primary and Secondary Prevention of Women’s Cancers

1 May 2025

Date: 23 June 2025, Monday Time: 3pm – 4pm Venue: Clifford Allbutt lecture theatre, Clifford Allbutt Building, Cambridge Biomedical Campus, Cambridge, CB2 0AH Please register here . Abstract: I nnovative strategies to enhance the primary and secondary prevention of women’s cancers are urgently needed . Traditional...


Read more at: Assessment of a Polygenic Risk Score in Screening for Prostate Cancer

Assessment of a Polygenic Risk Score in Screening for Prostate Cancer

23 April 2025

Our BARCODE 1 study was published by New England Journal of Medicine and was led by the Institute of Cancer Research. Professor Nora Pashayan has contributed to the study as a Co-investigator and Co-author. This publication has attracted attention from several media outlets. Please find the corresponding links below for...


Read more at: CCGE researchers evaluate the contribution of gene variants to cancer risk for multiple cancer types

CCGE researchers evaluate the contribution of gene variants to cancer risk for multiple cancer types

13 March 2025

In a paper published in the American Journal of Human Genetics, CCGE researchers used data from UK Biobank to evaluate the contribution of coding variants to the heritability of 11 cancer types. The results show that gene variants make the largest contribution for ovarian cancer, followed by endometrial, pancreatic and...


Read more at: £10 million programme to use AI and state-of-the-art analytics to fight cancer

£10 million programme to use AI and state-of-the-art analytics to fight cancer

24 January 2025

Cambridge researchers are to lead a £10million project that could result in doctors being able to predict your individual chances of getting cancer and offer personalised detection and prevention. To read the full article...


Read more at: £10m funding for new programme to help identify individual cancer risk

£10m funding for new programme to help identify individual cancer risk

24 January 2025

Early detection of cancer is key to saving lives, because cancer diagnosed at an early stage, when it isn’t too large and hasn’t spread, is more likely to be treated successfully. But according to our analysis of NHS figures, currently only 54.4% of cancers are diagnosed at stages one and two*. But that could all be about...